Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I study of CBS004

Trial Profile

Phase I study of CBS004

Status: Planning
Phase of Trial: Phase I

Latest Information Update: 29 Nov 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs CBS 004 (Primary)
  • Indications Cutaneous lupus erythematosus; Systemic lupus erythematosus; Systemic scleroderma
  • Focus Adverse reactions
  • Most Recent Events

    • 27 Nov 2023 According to an AnaptysBio media release, the company plan to file IND application which will be renamed ANB101, in H2 2024.
    • 30 Nov 2021 New trial record
    • 15 Nov 2021 According to a Centessa Pharmaceuticals media release, the company expects to submit an Investigational New Drug application with the U.S. Food and Drug Administration for CBS004 in 2H 2022 and initiate this study shorty thereafter.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top